Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component

about

Soluble Toll-Like Receptor 4 Impairs the Interaction of Shiga Toxin 2a with Human Serum Amyloid P Component

Item

http://www.wikidata.org/entity/Q58723219

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 18 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@en

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@nl

type

Item

label

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@en

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@nl

prefLabel

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@en

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@nl

P1476

Soluble Toll-Like Receptor 4 I ...... uman Serum Amyloid P Component

@en

P2093

Gaia Scavia

http://www.w3.org/2001/XMLSchema#string

Gianluigi Ardissino

http://www.w3.org/2001/XMLSchema#string

Maurizio Brigotti

http://www.w3.org/2001/XMLSchema#string

Pier Luigi Tazzari

http://www.w3.org/2001/XMLSchema#string

Stefano Morabito

http://www.w3.org/2001/XMLSchema#string

Valentina Arfilli

http://www.w3.org/2001/XMLSchema#string

Xiaohua He

http://www.w3.org/2001/XMLSchema#string

P2860

Pathogen recognition and innate immunity

Negative regulation of toll-like receptor-mediated immune responses

Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.

Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells.

Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Enterohaemorrhagic Escherichia coli in human medicine.

Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome.

Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.

P304

379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/TOXINS10090379

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Ricci

Domenica Carnicelli

P577

2018-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30231570

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

toxicology

P932

6162853

http://www.w3.org/2001/XMLSchema#string